Incidence and risk of proteinuria associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis of randomized controlled trials
Zhang, Wei, Feng, Li-jin, teng, Fei, Li, Yan-hong, Zhang, Xi, Ran, Yu-geLanguage:
english
Journal:
Expert Review of Clinical Pharmacology
DOI:
10.1080/17512433.2020.1734450
Date:
February, 2020
File:
PDF, 2.02 MB
english, 2020